LabChip GX Touch Nucleic Acid Analyzer

LabChip® GX Touch™ Nucleic Acid Analyzer

DNA and RNA quantitation and sizing can be done in seconds using automated capillary electrophoresis separation. The LabChip® GX Touch™ nucleic acid analyzer's microfluidic technology generates reproducible, high-resolution data and is optimal for:

• Fast, high-throughput QC analysis of NGS libraries for detection of mutations associated with SARS-CoV-2

• NGS library preparation (smear and fragment analysis) and quality control

• RNA and DNA fragment analysis (including cell-free DNA, DNA isolated from FFPE samples, and PCR-free libraries)

• Quantitation and qualification for CRISPR fragment analysis

• Screening nucleic acid source material for SARS-CoV-2 vaccine development

• Characterization and QC of small RNA molecules and CRISPR/Cas9 gRNA

• Multiplex Detection of SARS-CoV-2 Multiplex Detection of SARS-CoV-2 Variants of Concern using ARMS-PCR

The LabChip GX Touch nucleic acid analyzer also supports a variety of DNA and RNA analysis, which provides unparallel genomic data quality with minimal input requirements. When the concentrations are low, and samples are precious, The LabChip® DNA High Sens and RNA Pico assays are ideal choice for reliable measurement and sample preservation. With complete analysis of genomic material in about 30 seconds, the LabChip GX Touch nucleic acid analyzer eliminates the nucleic acid quantitation workflow bottleneck. High-resolution analysis provides exact sizing and quantitation of DNA fragments and smears down to 5 bp from samples as small as 2 pg/µL.

The system offers a broad variety of DNA analysis options, including the NGS 3K assay, which provides unparalleled genomic data quality with minimal input requirements. This high degree of sensitivity also makes it the ideal instrument for gDNA, cfDNA, and PCR-free DNA quantitation, where concentrations are low, samples are precious and their preservation is essential.

Purity and Integrity Analysis of mRNA-based Vaccines

By using LabChip® RNA Assay, researchers at Merck developed an assay to characterize purity and integrity of mRNA vaccines. This fast, easy and efficient workflow helped speed up vaccine development and meet increased manufacturing high volume demand.

产品特点：

The Comprehensive Solution for Genomic Sizing & Quantitation

• Quantitate DNA and RNA sample integrity hours faster than agarose gels

• Maximize rare or low-concentration samples like cfDNA, PCR-free libraries, and ChIP-seq libraries

• Accurate quantitation down to 25 pg/µL for DNA smears and 0.5 pg/µL for fragments

• NGS library prep analysis and QC

• Flexible throughput options make it cost-efficient – 96-well or 384-well (HT) format

• Data visualization options (electropherogram, virtual gel, or tabular report)

应用：

• Complete NGS workflows

• CRISPR Fragment Analysis

• Vaccine Development

   

仪器尺寸规格：

Windows 10-compatible software

配套试剂和芯片：